TARS.OQ - Tarsus Pharmaceuticals Inc
William Blair & Company
Fourth-Quarter Earnings; Xdemvy Growth to Continue in 2026 as Peak Sales Guidance Increases to >$2 Billion, Pipeline Advances
公司
TARS.OQ
日期
2026-02-24
分析师
Mr. Lachlan Hanbury-Brown
页数
8 页
需要登录
请登录后购买研报或生成音频内容。